Internal Medicine, Endocrinology, Diabetes, & Metabolism · Raleigh, NC
NPI
1346431004
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
6729 Falls of Neuse Rd Ste 201
Raleigh, NC, 27615
Phone (919) 844-6218
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
758 services
Medicare patients, 2024
334
Average age 73
Drug cost, 2024
$2.2M
2,973 prescriptions
Company payments, 2025
$174
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amit A Patel was code 99214 (office e&m - established), 476 times for 250 patients. In total Amit A Patel billed 758 services in 12 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 476 | 250 | $84.25 | $40K |
| 95251 Test - Miscellaneous | Office | 118 | 49 | $24.82 | $2,929 |
| 99205 Office E&M - New | Office | 62 | 62 | $154.59 | $9,585 |
| 99204 Office E&M - New | Office | 37 | 37 | $113.46 | $4,198 |
| 99213 Office E&M - Established | Office | 27 | 18 | $60.27 | $1,627 |
| 96372 Injection Administration | Office | 16 | 12 | $8.65 | $138 |
By year: 2022 $55K for 611 services; 2023 $63K for 762 services; 2024 $60K for 758 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amit A Patel prescribed most often to Medicare patients was Levothyroxine Sodium, with 402 prescriptions and refills. In total Amit A Patel wrote 2,973 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 402 | 1,010 | 120 | $4,629 |
| Metformin Hcl Er Metformin Hcl | 221 | 570 | 59 | $2,307 |
| Methimazole Generic | 166 | 397 | 49 | $1,535 |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 146 | 373 | 75 | $20K |
| Ozempic Semaglutide | 137 | 257 | 41 | $248K |
| Metformin Hcl Generic | 99 | 281 | 28 | $669 |
| Liothyronine Sodium Generic | 88 | 232 | 33 | $2,425 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 85 | 223 | 40 | $13K |
| Jardiance Empagliflozin | 76 | 182 | 27 | $105K |
| Humalog Kwikpen U-100 Insulin Lispro | 73 | 181 | 35 | $36K |
| Trulicity Dulaglutide | 65 | 112 | 18 | $110K |
| Synthroid Levothyroxine Sodium | 60 | 153 | 22 | $5,576 |
| Farxiga Dapagliflozin Propanediol | 59 | 125 | 18 | $67K |
| Glimepiride Generic | 58 | 148 | 16 | $430 |
| Alendronate Sodium Generic | 46 | 128 | 20 | $319 |
Brand drugs: 1,393 claims; generic drugs: 1,276 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amit A Patel $174 ($174 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbott Laboratories with $140.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.